EP1765381

TREATMENT OF NEUROLOGICAL DISORDERS WITH HAEMATOPOIETIC GROWTH FACTORS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    29.12.2004
  • EP published:
    13.10.2010
  • EP application number:
    04806493.5
  • Max expiry date:
    28.12.2024
  • Title:
    TREATMENT OF NEUROLOGICAL DISORDERS WITH HAEMATOPOIETIC GROWTH FACTORS

Timeline

Today
29.12.2004EP application
13.10.2010EP Publication

Owner

  • Name:
    Sygnis Bioscience GmbH & Co. KG
  • Address:
    Im Neuenheimer Feld 515, 69120, Heidelberg, DE

Inventor

  • Name:
    SCHAEBITZ, Wolf-Ruediger
  • Address:
    Bielefeld, DE
  • Name:
    SCHNEIDER, Armin
  • Address:
    Heidelberg, DE
  • Name:
    KRUEGER, Carola
  • Address:
    Neustadt/Weinstr., DE
  • Name:
    SOMMER, Clemens
  • Address:
    Nieder-Olm, DE
  • Name:
    SCHWAB, Stefan
  • Address:
    Erlangen, DE
  • Name:
    KOLLMAR, Rainer
  • Address:
    Erlangen, DE
  • Name:
    MAURER, Martin
  • Address:
    Tübingen, DE
  • Name:
    WEBER, Daniela
  • Address:
    Heidelberg, DE
  • Name:
    GASSLER, Nikolaus
  • Address:
    Aachen, DE

Priority

  • Number:
    880101
  • Date:
    30.6.2004
  • Country:
    US

Classification

  • Categories:
    A61K 38/19, A61K 38/20, A61K 35/30, C12N 5/074, A61P 25/28, A61P 25/24, A61P 25/16, A61P 25/14, A61P 9/10, A61P 27/06, A61P 25/02

Upload documents